Article ; Online: A retrospective study of 222 patients with newly diagnosed primary central nervous system lymphoma-Outcomes indicative for improved survival overtime.
2023 Volume 41, Issue 5, Page(s) 838–847
Abstract: Primary central nervous system lymphoma (PCNSL) is a rare disease with an incidence of 0.4/per 100,000 person-years. As there is a limited number of prospective randomized trials in PCNSL, large retrospective studies on this rare disease may yield ... ...
Abstract | Primary central nervous system lymphoma (PCNSL) is a rare disease with an incidence of 0.4/per 100,000 person-years. As there is a limited number of prospective randomized trials in PCNSL, large retrospective studies on this rare disease may yield information that might prove useful for the future design of randomized clinical trials. We retrospectively analyzed the data of 222 newly diagnosed PCNSL patients treated in five referral centers in Israel between 2001 and 2020. During this period, combination therapy became the treatment of choice, rituximab has been added to the induction therapy, and consolidation with irradiation was largely laid off and was mostly replaced by high-dose chemotherapy with or without autologous stem cell transplantation (HDC-ASCT). Patients older than 60 comprised 67.5% of the study population. First-line treatment included high-dose methotrexate (HD-MTX) in 94% of patients with a median MTX dose of 3.5 g/m |
---|---|
MeSH term(s) | Humans ; Retrospective Studies ; Rituximab/therapeutic use ; Hematopoietic Stem Cell Transplantation/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Prospective Studies ; Rare Diseases/drug therapy ; Rare Diseases/etiology ; Central Nervous System Neoplasms/drug therapy ; Transplantation, Autologous ; Methotrexate ; Lymphoma/pathology ; Central Nervous System/pathology |
Chemical Substances | Rituximab (4F4X42SYQ6) ; Methotrexate (YL5FZ2Y5U1) |
Language | English |
Publishing date | 2023-07-05 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 604884-5 |
ISSN | 1099-1069 ; 0278-0232 |
ISSN (online) | 1099-1069 |
ISSN | 0278-0232 |
DOI | 10.1002/hon.3198 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1816: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.